We are live on ! Find out more
RVMD icon

Revolution Medicines
RVMD

90 hedge funds and large institutions have $1.98B invested in Revolution Medicines in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

255% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 11

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

33% more capital invested

Capital invested by funds: $1.49B → $1.98B (+$495M)

29% more funds holding in top 10

Funds holding in top 10: 7 → 9 (+2)

17% more funds holding

Funds holding: 77 → 90 (+13)

6.35% more ownership

Funds ownership: 80.05% → 86.4% (+6.4%)

Holders
90
Holders Change
+13
Holders Change %
+16.88%
% of All Funds
1.82%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.18%
New
25
Increased
39
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$59M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$55M
3
BlackRock
BlackRock
New York
+$39.6M
4
BI
BVF Inc
California
+$36.1M
5
State Street
State Street
Massachusetts
+$22.4M

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$27.7M
2
ACA
Avoro Capital Advisors
New York
-$9.6M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.21M
4
PA
Perceptive Advisors
New York
-$3.48M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$3.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
26
Perceptive Advisors
New York
$7.8M -$3.48M -125,776 -36%
Wellington Management Group
27
Wellington Management Group
Massachusetts
$7.09M -$2.19M -78,902 -28%
N
28
Nuveen
North Carolina
$5.29M +$643K +23,210 +18%
JMPWA
29
JP Morgan Private Wealth Advisors
California
$4.66M +$3.71M +133,776 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$4.5M +$2.03M +73,404 +131%
Fidelity International
31
Fidelity International
Bermuda
$3.65M – – –
VC
32
Vivo Capital
California
$3.46M -$2.77M -100,001 -50%
TOPU
33
Trustees of Princeton University
New Jersey
$3.16M +$2.51M +90,758 New
CCM
34
Copernicus Capital Management
California
$2.82M +$2.24M +81,000 New
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$2.79M +$1.32M +47,655 +147%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$2.03M +$1.02M +36,918 +172%
Victory Capital Management
37
Victory Capital Management
Texas
$1.95M +$1.01M +36,593 +189%
AllianceBernstein
38
AllianceBernstein
Tennessee
$1.95M +$935K +33,773 +153%
Goldman Sachs
39
Goldman Sachs
New York
$1.87M -$2.08M -75,056 -58%
Morgan Stanley
40
Morgan Stanley
New York
$1.82M +$621K +22,431 +75%
Ameriprise
41
Ameriprise
Minnesota
$1.75M +$161K +5,795 +13%
Wells Fargo
42
Wells Fargo
California
$1.62M +$188K +6,801 +17%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$1.45M +$629K +22,719 +121%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.26M +$274K +9,900 +38%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$1.22M +$612K +22,100 +173%
WP
46
Woodline Partners
California
$971K +$773K +27,911 New
Ensign Peak Advisors
47
Ensign Peak Advisors
Utah
$875K +$697K +25,148 New
RJFSA
48
Raymond James Financial Services Advisors
Florida
$840K +$669K +24,152 New
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$814K – – –
AIG
50
American International Group
New York
$803K +$391K +14,106 +157%
1
2
3 4

RVMD Hedge Fund Activity: Q3 2020 in Review

90 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines (RVMD) for Q3 2020, worth a combined $1.98B — up 33% from $1.49B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new RVMD positions and 12 closed out — a net gain of 13 holders — while 39 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $59M. The largest seller was TRV GP III, cutting an estimated $27.7M.

  • 90 institutional investors held Revolution Medicines (RVMD) as of Q3 2020, up from 77 in Q2 2020.
  • Funds reported $1.98B of Revolution Medicines stock for Q3 2020, up 33% quarter-over-quarter.
  • 25 funds opened new Revolution Medicines positions in Q3 2020 and 12 closed out, a net change of +13 holders.
  • The largest Revolution Medicines buyer in Q3 2020 was Vanguard Group, an estimated $59M added.
  • The largest Revolution Medicines seller in Q3 2020 was TRV GP III, an estimated $27.7M sold.

Based on aggregated 13F filings for Q3 2020.